BRIEF-Shire Says Granted Orphan Drug Status For Crohn's Disease Treatment For Children

* SHIRE - U.S. FDA GRANTS ORPHAN DRUG DESIGNATION FOR INVESTIGATIONAL SHP647 FOR TREATMENT OF PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

Read more...
Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

Whoops, looks like something went wrong.